A phase Ib study of oral Chk1 inhibitor LY2880070 in combination with gemcitabine - Will it affect clinicians - Quincy S. Chu MD - University of Alberta @UAlberta #advancedcancer #metasta...

A phase Ib study of oral Chk1 inhibitor LY2880070 in combination with gemcitabine - Will it affect clinicians - Quincy S. Chu MD - University of Alberta @UAlberta #advancedcancer #metasta...

User Photo
Cancer-News

2 weeks
14 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Quincy S. Chu, MD - University of Alberta discusses A phase Ib study of oral Chk1 inhibitor LY2880070 in combination with gemcitabine in patients with advanced or metastatic cancer



ASCO


https://meetinglibrary.asco.org/record/187856/abstract
Up Next Autoplay